We are passionate about our purpose, we are committed to each other and we act as one team with a heightened sense of urgency. We plan to employ our validated TPE® technology to expand our pipeline of oral therapeutic options for patients with rare diseases to use in place of painful and burdensome injections.
Our Values
Our Values
Persistence
We leverage our resiliency in the face of challenges to pursue our mission.
Passion for Results
We embed integrity and energy in all we do to achieve superior results built on a foundation for sustainable and profitable growth.
Ingenuity
We utilize our innovative technology to develop novel solutions that address significant unmet medical needs.
Commitment to People
We focus on the impact of our actions and are responsible to patients, our community and our people.
Sense of Urgency
We act with speed, efficiency and accountability to benefit patients, employees, and shareholders.
Management Team
Chiasma’s team has the development and commercialization expertise needed to bring novel oral therapies to patients with rare diseases to overcome their everyday challenges associated with existing injectables.

Raj Kannan

William Ludlam, M.D., Ph.D.

Anand Varadan

John Doyle

Drew Enamait

Lee Giguere

Shoshie Katz

Gary Patou, M.D.
